2/25/26 17:00 | 2/24/26 | CGEM | Cullinan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -52 | 14.47 | 0 | -4 | -3 | 128 | D | | | | | | | | | | | | | | |
2/23/26 17:00 | 2/20/26 | CGEM | Cullinan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -51 | 13.62 | 0 | -4 | -3 | 132 | D | | | | | | | | | | | | | | |
12/19/25 17:00 | 12/18/25 | CGEM | Cullinan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -34 | 9.67 | 0 | -3 | -3 | 135 | D | | | | | | | | | | | | | | |
2/27/25 17:00 | 2/25/25 | CGEM | Cullinan Therapeutics, Inc. | | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -32 | 8.53 | 0 | -4 | -3 | 137 | D | | | | | | | | | | | | | | |
12/20/24 17:00 | 12/18/24 | CGEM | Cullinan Therapeutics, Inc. | | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -40 | 11.41 | 0 | -3 | -4 | 91 | D | | | | | | | | | | | | | | |
12/22/23 17:30 | 12/21/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -12 | 8.50 | 0 | -1 | -3 | 44 | D | | | | | | | | | | | | | | |
12/20/23 18:00 | 12/18/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -2 | 8.22 | 0 | 0 | -1 | 46 | D | | | | | | | | | | | | | | |
6/21/23 16:17 | 6/20/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -4 | 12.94 | 0 | 0 | -1 | 46 | D | | | | | | | | | | | | | | |
5/19/23 16:45 | 5/18/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -3 | 8.76 | 0 | 0 | -1 | 46 | D | | | | | | | | | | | | | | |
4/20/23 16:30 | 4/18/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -3 | 10.71 | 0 | 0 | -1 | 46 | D | | | | | | | | | | | | | | |
3/27/23 16:05 | 3/20/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | S | -3 | 11.32 | 0 | 0 | -1 | 47 | D | | | | | | | | | | | | | | |
6/2/22 16:32 | 6/1/22 | GNCA | Genocea Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | CHIEF LE | S | 0 | 0.0601 | 0 | -3 | -5 | 43 | D | | | | | | | | | | | | | | |